ARK Genomic Revolution ETF vs ClearPoint Neuro Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | CLPT | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $44.55 | $29.60 |
52-Week Low | $24.02 | $8.66 |
Market Cap | — | $454.21M |
Enterprise Value | — | $488.79M |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →